Structure

Physi-Chem Properties

Molecular Weight:  532.21
Volume:  543.27
LogP:  5.403
LogD:  4.539
LogS:  -6.165
# Rotatable Bonds:  7
TPSA:  92.68
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.308
Synthetic Accessibility Score:  3.998
Fsp3:  0.323
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.825
MDCK Permeability:  1.375861120322952e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.013
Plasma Protein Binding (PPB):  95.41112518310547%
Volume Distribution (VD):  0.521
Pgp-substrate:  4.037883281707764%

ADMET: Metabolism

CYP1A2-inhibitor:  0.166
CYP1A2-substrate:  0.9
CYP2C19-inhibitor:  0.978
CYP2C19-substrate:  0.636
CYP2C9-inhibitor:  0.958
CYP2C9-substrate:  0.951
CYP2D6-inhibitor:  0.565
CYP2D6-substrate:  0.541
CYP3A4-inhibitor:  0.835
CYP3A4-substrate:  0.849

ADMET: Excretion

Clearance (CL):  4.46
Half-life (T1/2):  0.09

ADMET: Toxicity

hERG Blockers:  0.167
Human Hepatotoxicity (H-HT):  0.09
Drug-inuced Liver Injury (DILI):  0.905
AMES Toxicity:  0.103
Rat Oral Acute Toxicity:  0.026
Maximum Recommended Daily Dose:  0.38
Skin Sensitization:  0.622
Carcinogencity:  0.098
Eye Corrosion:  0.003
Eye Irritation:  0.702
Respiratory Toxicity:  0.185

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC215400

Natural Product ID:  NPC215400
Common Name*:   Tiegusanin L
IUPAC Name:   n.a.
Synonyms:   Tiegusanin L
Standard InCHIKey:  ZUSDJUTXFWPDCB-UCZNXJLISA-N
Standard InCHI:  InChI=1S/C31H32O8/c1-17-13-20-14-23-29(38-16-37-23)30(35-4)25(20)26-21(15-22(32)28(34-3)31(26)36-5)27(18(17)2)39-24(33)12-11-19-9-7-6-8-10-19/h6-12,14-15,17-18,27,32H,13,16H2,1-5H3/b12-11+/t17-,18-,27-/m1/s1
SMILES:  C[C@@H]1Cc2cc3c(c(c2-c2c(cc(c(c2OC)OC)O)[C@@H]([C@@H]1C)OC(=O)/C=C/c1ccccc1)OC)OCO3
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL564434
PubChem CID:   44179267
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. DOI[10.1002/cjoc.20010190319]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. DOI[10.1016/j.tet.2008.10.079]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. PMID[11395273]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. PMID[18536373]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota aerial parts Erlang Mountain area of Sichuan Province, China 2007-SEP PMID[19413342]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. PMID[20681569]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7374 Seseli montanum Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11167 Prunus ssiori Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9834 Veronica austriaca Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6903 Lecanora straminea Species Lecanoraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7128 Cynthia savignyi n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 = 74100.0 nM PMID[529765]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 7300.0 nM PMID[529765]
NPT2 Others Unspecified Ratio CC50/EC50 = 10.2 n.a. PMID[529765]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC215400 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC230531
0.9669 High Similarity NPC476065
0.9542 High Similarity NPC475592
0.9536 High Similarity NPC475141
0.9474 High Similarity NPC473736
0.947 High Similarity NPC471154
0.947 High Similarity NPC477378
0.947 High Similarity NPC475229
0.943 High Similarity NPC311912
0.9408 High Similarity NPC217708
0.9408 High Similarity NPC297271
0.9408 High Similarity NPC16791
0.9408 High Similarity NPC53669
0.9408 High Similarity NPC77237
0.9408 High Similarity NPC126405
0.9408 High Similarity NPC477377
0.9408 High Similarity NPC474606
0.9408 High Similarity NPC308739
0.9408 High Similarity NPC24562
0.9404 High Similarity NPC475756
0.9404 High Similarity NPC224472
0.9371 High Similarity NPC88557
0.9286 High Similarity NPC238834
0.9272 High Similarity NPC474393
0.9272 High Similarity NPC474347
0.9245 High Similarity NPC83049
0.9245 High Similarity NPC118162
0.9245 High Similarity NPC320471
0.9226 High Similarity NPC473323
0.9221 High Similarity NPC312763
0.9221 High Similarity NPC198461
0.9211 High Similarity NPC470916
0.9211 High Similarity NPC24425
0.9205 High Similarity NPC252281
0.9205 High Similarity NPC327352
0.9205 High Similarity NPC102934
0.9205 High Similarity NPC316676
0.9205 High Similarity NPC477375
0.9205 High Similarity NPC198129
0.9205 High Similarity NPC252402
0.9205 High Similarity NPC325720
0.9145 High Similarity NPC322426
0.9145 High Similarity NPC477374
0.9145 High Similarity NPC477376
0.9085 High Similarity NPC473989
0.9085 High Similarity NPC316989
0.9073 High Similarity NPC474054
0.9068 High Similarity NPC79322
0.9067 High Similarity NPC121661
0.9067 High Similarity NPC73467
0.9067 High Similarity NPC87883
0.9067 High Similarity NPC326144
0.9057 High Similarity NPC473445
0.9057 High Similarity NPC42797
0.9032 High Similarity NPC149735
0.902 High Similarity NPC85141
0.9013 High Similarity NPC295297
0.9007 High Similarity NPC110763
0.9007 High Similarity NPC189239
0.9007 High Similarity NPC197352
0.9007 High Similarity NPC318286
0.9007 High Similarity NPC166506
0.9007 High Similarity NPC327651
0.9 High Similarity NPC291977
0.9 High Similarity NPC218510
0.9 High Similarity NPC469630
0.9 High Similarity NPC76415
0.8994 High Similarity NPC319749
0.8974 High Similarity NPC473425
0.8968 High Similarity NPC478268
0.8957 High Similarity NPC477883
0.8947 High Similarity NPC154971
0.8947 High Similarity NPC321958
0.8947 High Similarity NPC321696
0.8947 High Similarity NPC252286
0.8933 High Similarity NPC184684
0.8933 High Similarity NPC67467
0.8933 High Similarity NPC184641
0.8933 High Similarity NPC133934
0.8924 High Similarity NPC125495
0.8902 High Similarity NPC469506
0.8882 High Similarity NPC477702
0.8875 High Similarity NPC258322
0.8875 High Similarity NPC191352
0.8874 High Similarity NPC324962
0.8868 High Similarity NPC478269
0.8861 High Similarity NPC29727
0.8848 High Similarity NPC477881
0.8846 High Similarity NPC472612
0.8846 High Similarity NPC476434
0.8846 High Similarity NPC289967
0.8846 High Similarity NPC472611
0.8839 High Similarity NPC477381
0.8827 High Similarity NPC477884
0.8824 High Similarity NPC212890
0.882 High Similarity NPC280778
0.8808 High Similarity NPC230538
0.8808 High Similarity NPC103637
0.8808 High Similarity NPC229172
0.8808 High Similarity NPC36531
0.879 High Similarity NPC470769
0.8782 High Similarity NPC477379
0.8774 High Similarity NPC90896
0.8774 High Similarity NPC106138
0.8774 High Similarity NPC283839
0.8773 High Similarity NPC59516
0.8765 High Similarity NPC469475
0.8765 High Similarity NPC469518
0.8758 High Similarity NPC478267
0.8758 High Similarity NPC475868
0.8742 High Similarity NPC11411
0.8742 High Similarity NPC477380
0.8734 High Similarity NPC348849
0.8734 High Similarity NPC178195
0.8733 High Similarity NPC471183
0.8726 High Similarity NPC302610
0.8718 High Similarity NPC469707
0.8718 High Similarity NPC225815
0.8718 High Similarity NPC145979
0.8718 High Similarity NPC185955
0.8718 High Similarity NPC218041
0.8718 High Similarity NPC214326
0.8718 High Similarity NPC9933
0.8718 High Similarity NPC260781
0.8718 High Similarity NPC469706
0.8718 High Similarity NPC182368
0.8704 High Similarity NPC249070
0.8704 High Similarity NPC469512
0.8701 High Similarity NPC40222
0.8701 High Similarity NPC268515
0.8696 High Similarity NPC268718
0.8696 High Similarity NPC150943
0.8696 High Similarity NPC91634
0.8693 High Similarity NPC472712
0.8693 High Similarity NPC172171
0.8693 High Similarity NPC187774
0.8693 High Similarity NPC297342
0.8693 High Similarity NPC118385
0.8693 High Similarity NPC239254
0.8693 High Similarity NPC473046
0.8693 High Similarity NPC472713
0.869 High Similarity NPC477880
0.869 High Similarity NPC477882
0.8688 High Similarity NPC477885
0.8688 High Similarity NPC163527
0.8688 High Similarity NPC181168
0.8688 High Similarity NPC115281
0.8684 High Similarity NPC191231
0.8684 High Similarity NPC41782
0.8671 High Similarity NPC115203
0.8671 High Similarity NPC150442
0.8667 High Similarity NPC117911
0.8667 High Similarity NPC865
0.8645 High Similarity NPC39657
0.8645 High Similarity NPC183083
0.8645 High Similarity NPC137352
0.8634 High Similarity NPC173726
0.8634 High Similarity NPC241600
0.8625 High Similarity NPC228357
0.8609 High Similarity NPC201404
0.8609 High Similarity NPC53722
0.8609 High Similarity NPC290714
0.8608 High Similarity NPC176186
0.8608 High Similarity NPC169404
0.8608 High Similarity NPC21902
0.8608 High Similarity NPC53587
0.86 High Similarity NPC143895
0.86 High Similarity NPC133025
0.8599 High Similarity NPC472709
0.8599 High Similarity NPC472710
0.859 High Similarity NPC261122
0.859 High Similarity NPC477879
0.859 High Similarity NPC201148
0.859 High Similarity NPC80732
0.859 High Similarity NPC300262
0.859 High Similarity NPC199311
0.859 High Similarity NPC93924
0.859 High Similarity NPC210611
0.859 High Similarity NPC215095
0.859 High Similarity NPC192763
0.859 High Similarity NPC28651
0.859 High Similarity NPC3460
0.8581 High Similarity NPC190714
0.8581 High Similarity NPC317053
0.8581 High Similarity NPC199928
0.8581 High Similarity NPC260397
0.8581 High Similarity NPC99515
0.8581 High Similarity NPC324492
0.858 High Similarity NPC63061
0.8571 High Similarity NPC470827
0.8571 High Similarity NPC110063
0.8571 High Similarity NPC207584
0.8571 High Similarity NPC19947
0.8563 High Similarity NPC178737
0.8563 High Similarity NPC471181
0.8562 High Similarity NPC5262
0.8562 High Similarity NPC287124
0.8562 High Similarity NPC140502
0.8562 High Similarity NPC472714
0.8553 High Similarity NPC65591

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC215400 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.875 High Similarity NPD6234 Discontinued
0.8553 High Similarity NPD37 Approved
0.8509 High Similarity NPD4965 Approved
0.8509 High Similarity NPD4966 Approved
0.8509 High Similarity NPD4967 Phase 2
0.8494 Intermediate Similarity NPD7228 Approved
0.8415 Intermediate Similarity NPD7199 Phase 2
0.8313 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD1653 Approved
0.8129 Intermediate Similarity NPD7266 Discontinued
0.8061 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD3818 Discontinued
0.8013 Intermediate Similarity NPD3027 Phase 3
0.8012 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7473 Discontinued
0.8 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7977 Intermediate Similarity NPD7240 Approved
0.7937 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD6232 Discontinued
0.7907 Intermediate Similarity NPD5844 Phase 1
0.7861 Intermediate Similarity NPD7074 Phase 3
0.7857 Intermediate Similarity NPD1613 Approved
0.7857 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD7054 Approved
0.7771 Intermediate Similarity NPD6559 Discontinued
0.7765 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD7472 Approved
0.774 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD1465 Phase 2
0.7712 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6674 Discontinued
0.7665 Intermediate Similarity NPD1934 Approved
0.7647 Intermediate Similarity NPD7680 Approved
0.7647 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD6166 Phase 2
0.763 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD3705 Approved
0.7597 Intermediate Similarity NPD4908 Phase 1
0.7571 Intermediate Similarity NPD7685 Pre-registration
0.7571 Intermediate Similarity NPD7251 Discontinued
0.7529 Intermediate Similarity NPD3882 Suspended
0.7528 Intermediate Similarity NPD7808 Phase 3
0.7516 Intermediate Similarity NPD4060 Phase 1
0.7515 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD6797 Phase 2
0.7514 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD3817 Phase 2
0.743 Intermediate Similarity NPD7549 Discontinued
0.7414 Intermediate Similarity NPD7229 Phase 3
0.7412 Intermediate Similarity NPD8455 Phase 2
0.7412 Intermediate Similarity NPD7819 Suspended
0.7412 Intermediate Similarity NPD2801 Approved
0.7389 Intermediate Similarity NPD8313 Approved
0.7389 Intermediate Similarity NPD8312 Approved
0.7384 Intermediate Similarity NPD7075 Discontinued
0.7378 Intermediate Similarity NPD6190 Approved
0.7356 Intermediate Similarity NPD8127 Discontinued
0.7326 Intermediate Similarity NPD7768 Phase 2
0.7317 Intermediate Similarity NPD3750 Approved
0.7299 Intermediate Similarity NPD5494 Approved
0.7297 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD3620 Phase 2
0.7273 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD1610 Phase 2
0.7247 Intermediate Similarity NPD3751 Discontinued
0.7239 Intermediate Similarity NPD5763 Approved
0.7239 Intermediate Similarity NPD5762 Approved
0.7235 Intermediate Similarity NPD4380 Phase 2
0.7228 Intermediate Similarity NPD6841 Approved
0.7228 Intermediate Similarity NPD6842 Approved
0.7228 Intermediate Similarity NPD6843 Phase 3
0.7215 Intermediate Similarity NPD4625 Phase 3
0.7212 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD2861 Phase 2
0.7197 Intermediate Similarity NPD3018 Phase 2
0.7195 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD1511 Approved
0.7184 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD3749 Approved
0.7179 Intermediate Similarity NPD8151 Discontinued
0.717 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD6959 Discontinued
0.7152 Intermediate Similarity NPD1652 Phase 2
0.7143 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD422 Phase 1
0.7143 Intermediate Similarity NPD6355 Discontinued
0.7143 Intermediate Similarity NPD5124 Phase 1
0.7143 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2533 Approved
0.7143 Intermediate Similarity NPD2534 Approved
0.7143 Intermediate Similarity NPD2532 Approved
0.7143 Intermediate Similarity NPD230 Phase 1
0.7119 Intermediate Similarity NPD3787 Discontinued
0.7108 Intermediate Similarity NPD8166 Discontinued
0.7101 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD1512 Approved
0.7093 Intermediate Similarity NPD7411 Suspended
0.7076 Intermediate Similarity NPD7458 Discontinued
0.7076 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD5402 Approved
0.7063 Intermediate Similarity NPD3764 Approved
0.7063 Intermediate Similarity NPD6798 Discontinued
0.7059 Intermediate Similarity NPD1357 Approved
0.7055 Intermediate Similarity NPD7097 Phase 1
0.7052 Intermediate Similarity NPD6801 Discontinued
0.7051 Intermediate Similarity NPD2982 Phase 2
0.7051 Intermediate Similarity NPD2983 Phase 2
0.7039 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD1091 Approved
0.7013 Intermediate Similarity NPD4626 Approved
0.7012 Intermediate Similarity NPD3748 Approved
0.7006 Intermediate Similarity NPD4628 Phase 3
0.7 Intermediate Similarity NPD7095 Approved
0.7 Intermediate Similarity NPD5283 Phase 1
0.6993 Remote Similarity NPD1548 Phase 1
0.6989 Remote Similarity NPD8434 Phase 2
0.6987 Remote Similarity NPD2981 Phase 2
0.6983 Remote Similarity NPD3926 Phase 2
0.6982 Remote Similarity NPD4357 Discontinued
0.6982 Remote Similarity NPD6799 Approved
0.6975 Remote Similarity NPD4140 Approved
0.697 Remote Similarity NPD2935 Discontinued
0.6959 Remote Similarity NPD5403 Approved
0.6957 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6949 Remote Similarity NPD919 Approved
0.6948 Remote Similarity NPD5691 Approved
0.6946 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6946 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6943 Remote Similarity NPD4749 Approved
0.6941 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6936 Remote Similarity NPD7028 Phase 2
0.6936 Remote Similarity NPD6599 Discontinued
0.6928 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7435 Discontinued
0.6918 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6914 Remote Similarity NPD2977 Approved
0.6914 Remote Similarity NPD2978 Approved
0.6914 Remote Similarity NPD6233 Phase 2
0.6909 Remote Similarity NPD1510 Phase 2
0.6905 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7003 Approved
0.6905 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6905 Remote Similarity NPD4110 Phase 3
0.69 Remote Similarity NPD7827 Phase 1
0.6897 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6886 Remote Similarity NPD1549 Phase 2
0.6882 Remote Similarity NPD8054 Approved
0.6882 Remote Similarity NPD8053 Approved
0.6872 Remote Similarity NPD5006 Approved
0.6872 Remote Similarity NPD5005 Approved
0.6867 Remote Similarity NPD2438 Suspended
0.6867 Remote Similarity NPD228 Approved
0.6867 Remote Similarity NPD6099 Approved
0.6867 Remote Similarity NPD6100 Approved
0.6864 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6862 Remote Similarity NPD7906 Approved
0.6855 Remote Similarity NPD2797 Approved
0.685 Remote Similarity NPD7782 Clinical (unspecified phase)
0.685 Remote Similarity NPD7783 Phase 2
0.6848 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6842 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6842 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5401 Approved
0.6842 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6835 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6829 Remote Similarity NPD1933 Approved
0.6829 Remote Similarity NPD5735 Approved
0.6826 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6826 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6824 Remote Similarity NPD5058 Phase 3
0.6818 Remote Similarity NPD5563 Clinical (unspecified phase)
0.6818 Remote Similarity NPD5536 Phase 2
0.6816 Remote Similarity NPD6746 Phase 2
0.6807 Remote Similarity NPD4108 Discontinued
0.6802 Remote Similarity NPD6273 Approved
0.68 Remote Similarity NPD5090 Approved
0.68 Remote Similarity NPD5089 Approved
0.6796 Remote Similarity NPD5242 Approved
0.6795 Remote Similarity NPD5125 Phase 3
0.6795 Remote Similarity NPD5126 Approved
0.6788 Remote Similarity NPD6653 Approved
0.6786 Remote Similarity NPD6823 Phase 2
0.6782 Remote Similarity NPD3226 Approved
0.6782 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6782 Remote Similarity NPD4005 Discontinued
0.678 Remote Similarity NPD5353 Approved
0.678 Remote Similarity NPD6374 Clinical (unspecified phase)
0.677 Remote Similarity NPD5736 Approved
0.6769 Remote Similarity NPD6777 Approved
0.6769 Remote Similarity NPD6776 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data